Literature DB >> 34346744

SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.

Fengming Sun1,2, Xiuhua Wang1,2, Shun Tan3, Yunjie Dan1,2, Yanqiu Lu3, Juan Zhang1,2, Junli Xu4, Zhaoxia Tan1, Xiaomei Xiang1, Yi Zhou1, Weiwei He1, Xing Wan1, Wei Zhang1, Yaokai Chen3, Wenting Tan1,2, Guohong Deng1,2.   

Abstract

The dynamics of quasispecies afford RNA viruses a great fitness on cell tropism and host range. To study the quasispecies features and the intra-host evolution of SARS-CoV-2, we collected nine confirmed patients and sequenced the haplotypes of spike gene using a single-molecule real-time platform. Fourteen samples were extracted from sputum, nasopharyngeal swabs, or stool, which in total produced 283,655 high-quality circular consensus sequences. We observed a stable quasispecies structure that one master mutant (mean abundance ∼0.70), followed by numerous minor mutants (mean abundance ∼1.21 × 10-3). Under high selective pressure, minor mutants may obtain a fitness advantage and become the master ones. The later predominant substitution D614G existed in the minor mutants of more than one early patient. An epidemic variant had a possibility to be independently originated from multiple hosts. The mutant spectrums covered ∼85% amino acid variations of public genomes (GISAID; frequency ≥ 0.1) and likely provided an advantage mutation pool for the current/future epidemic variants. Notably, 32 of 35 collected antibody escape substitutions were preexistent in the early quasispecies. Virus populations in different tissues/organs revealed potentially independent replications. The quasispecies complexity of sputum samples was significantly lower than that of nasopharyngeal swabs (P = 0.02). Evolution analysis revealed that three continuous S2 domains (HR1, CH, and CD) had undergone a positive selection. Cell fusion-related domains may play a crucial role in adapting to the intrahost immune system. Our findings suggested that future epidemiologic investigations and clinical interventions should consider the quasispecies information that has missed by routine single consensus genome. IMPORTANCE RNA virus population in a host does not consist of a consensus single haplotype but rather an ensemble of related sequences termed quasispecies. The dynamics of quasispecies afford SARS-CoV-2 a great ability on genetic fitness during intrahost evolution. The process is likely achieved by changing the genetic characteristics of key functional genes, such as the spike glycoprotein. Previous studies have applied the next-generation sequencing (NGS) technology to evaluate the quasispecies of SARS-CoV-2, and results indicated a low genetic diversity of the spike gene. However, the NGS platform cannot directly obtain the full haplotypes without assembling, and it is also difficult to predict the extremely low-frequency variations. Therefore, we introduced a single-molecule real-time technology to directly obtain the haplotypes of the RNA population and further study the quasispecies features and intrahost evolution of the spike gene.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; quasispecies; spike gene

Year:  2021        PMID: 34346744     DOI: 10.1128/Spectrum.00261-21

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  14 in total

1.  Impact of Intrahost NS5 Nucleotide Variations on Dengue Virus Replication.

Authors:  Dayna Cheng; Sheng-Wen Huang; Wei-Xin Chin; Su-Jhen Hung; Huey-Pin Tsai; Justin Jang Hann Chu; Chiao-Hsuan Chao; Jen-Ren Wang
Journal:  Front Microbiol       Date:  2022-07-05       Impact factor: 6.064

2.  SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations.

Authors:  Brenda Martínez-González; María Eugenia Soria; Lucía Vázquez-Sirvent; Cristina Ferrer-Orta; Rebeca Lobo-Vega; Pablo Mínguez; Lorena de la Fuente; Carlos Llorens; Beatriz Soriano; Ricardo Ramos-Ruíz; Marta Cortón; Rosario López-Rodríguez; Carlos García-Crespo; Pilar Somovilla; Antoni Durán-Pastor; Isabel Gallego; Ana Isabel de Ávila; Soledad Delgado; Federico Morán; Cecilio López-Galíndez; Jordi Gómez; Luis Enjuanes; Llanos Salar-Vidal; Mario Esteban-Muñoz; Jaime Esteban; Ricardo Fernández-Roblas; Ignacio Gadea; Carmen Ayuso; Javier Ruíz-Hornillos; Nuria Verdaguer; Esteban Domingo; Celia Perales
Journal:  Pathogens       Date:  2022-06-08

3.  Anti-SARS-CoV-2 potential of Cissampelos pareira L. identified by connectivity map-based analysis and in vitro studies.

Authors:  Madiha Haider; Vivek Anand; M Ghalib Enayathullah; Yash Parekh; Sushma Ram; Surekha Kumari; Gayatri Panda; Manjari Shukla; Dhwani Dholakia; Arjun Ray; Sudipta Bhattacharyya; Upendra Sharma; Kiran Kumar Bokara; Bhavana Prasher; Mitali Mukerji
Journal:  BMC Complement Med Ther       Date:  2022-04-22

4.  Partial sequence conservation of SARS-CoV-2 NSP-2, NSP-12, and Spike in stool samples from Abadan, Iran.

Authors:  Milad Zandi; Saber Soltani; Alireza Tabibzadeh; Sepideh Nasimzadeh; Emad Behboudi; Armin Zakeri; Yousef Erfani; Shokrollah Salmanzadeh; Samaneh Abbasi
Journal:  Biotechnol Appl Biochem       Date:  2022-04-09       Impact factor: 2.724

Review 5.  Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease.

Authors:  János András Mótyán; Mohamed Mahdi; Gyula Hoffka; József Tőzsér
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

6.  Prediction of SARS-CoV-2 Variant Lineages Using the S1-Encoding Region Sequence Obtained by PacBio Single-Molecule Real-Time Sequencing.

Authors:  Sébastien Lhomme; Justine Latour; Nicolas Jeanne; Pauline Trémeaux; Noémie Ranger; Marion Migueres; Gérald Salin; Cécile Donnadieu; Jacques Izopet
Journal:  Viruses       Date:  2021-12-18       Impact factor: 5.048

7.  Comparative analysis of SARS-CoV-2 quasispecies in the upper and lower respiratory tract shows an ongoing evolution in the spike cleavage site.

Authors:  Stefano Gaiarsa; Federica Giardina; Gherard Batisti Biffignandi; Guglielmo Ferrari; Aurora Piazza; Monica Tallarita; Federica Novazzi; Claudio Bandi; Stefania Paolucci; Francesca Rovida; Giulia Campanini; Antonio Piralla; Fausto Baldanti
Journal:  Virus Res       Date:  2022-04-14       Impact factor: 6.286

8.  SARS-CoV-2 Point Mutation and Deletion Spectra and Their Association with Different Disease Outcomes.

Authors:  Brenda Martínez-González; María Eugenia Soria; Lucía Vázquez-Sirvent; Cristina Ferrer-Orta; Rebeca Lobo-Vega; Pablo Mínguez; Lorena de la Fuente; Carlos Llorens; Beatriz Soriano; Ricardo Ramos; Marta Cortón; Rosario López-Rodríguez; Carlos García-Crespo; Isabel Gallego; Ana Isabel de Ávila; Jordi Gómez; Luis Enjuanes; Llanos Salar-Vidal; Jaime Esteban; Ricardo Fernandez-Roblas; Ignacio Gadea; Carmen Ayuso; Javier Ruíz-Hornillos; Nuria Verdaguer; Esteban Domingo; Celia Perales
Journal:  Microbiol Spectr       Date:  2022-03-29

9.  Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants.

Authors:  Matthew R Chang; Hanzhong Ke; Christian D Coherd; Yufei Wang; Kiyomi Mashima; Gabriella M Kastrunes; Chiung-Yu Huang; Wayne A Marasco
Journal:  EBioMedicine       Date:  2022-05-06       Impact factor: 11.205

10.  Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis.

Authors:  Joseph Thomas Ortega; Beata Jastrzebska; Hector Rafael Rangel
Journal:  Pathogens       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.